Expanding the phenotype of BICD2 mutations toward skeletal muscle involvement
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received May 3, 2016
- Accepted in final form August 12, 2016
- First Published October 26, 2016.
Article Versions
- Previous version (October 26, 2016 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Andreas Unger, PhD,
- Gabriele Dekomien, MD,
- Anne Güttsches, MD,
- Thomas Dreps,
- Rudolf Kley, MD,
- Martin Tegenthoff, MD,
- Andreas Ferbert, MD,
- Joachim Weis, MD,
- Christoph Heyer, MD, PhD,
- Wolfgang A. Linke, Phd,
- Lilian Martinez-Carrera,
- Markus Storbeck, MD,
- Brunhilde Wirth, PhD,
- Sabine Hoffjan, MD and
- Matthias Vorgerd, MD
- Andreas Unger, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Gabriele Dekomien, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Anne Güttsches, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Thomas Dreps,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Rudolf Kley, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) German Research Foundation (KL2487/2-2)
NONE
NONE
NONE
NONE
NONE
NONE
- Martin Tegenthoff, MD,
NONE
NONE
NONE
NONE
1. Device for influencing brain functions of a human being US patent No 8046083
NONE
NONE
NONE
NONE
NONE
NONE
NONE
DFG
NONE
Heimer Stiftung f?r Muskelforschung
NONE
see No 5
NONE
NONE
NONE
NONE
- Andreas Ferbert, MD,
NONE
NONE
Speakers honorarium from Daiichi Sankyo
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Joachim Weis, MD,
NONE
NONE
NONE
Editorial board member Acta Neuropathologica, Aktuelle Neurologie
NONE
Book editor “Peripheral nerve disorders: Pathology and genetics”, Wiley Blackwell
NONE
NONE
NONE
NONE
NONE
NONE
(1) German Ministry of Science and Education, MD-Net, DLR 360240, 2006-2012, (2) European Union, MEST-CT-2005-120589, 2005-2010, (3) Belgian Science Policy, R/uapa/P6/I/ WEIS, 2007-2012, (4) German Ministry of Science and Education, ID 40 2010-2014, (5) German Research Foundation (DFG), WE 1406/13-1, 2010-2016 (6) German Ministry of Science and Education, MND-Net, 2012-2015 (7) DFG; AK 469/1 (8) German Ministry of Science and Education, CMT-Net, 2015-2018, (9) EU Joint Program Neurodegenerative Disease Research (JPND), 2015-2018
(1) JARA Brain
(1) German Research Foundation, WE 1406/13-1, (2) German Society for Muscle Diseases, (3) Jackstaedt Foundation, (4)German Research Foundation, BiMEA
NONE
NONE
NONE
NONE
NONE
NONE
- Christoph Heyer, MD, PhD,
NONE
NONE
Speaker honoraria provided by Bayer Healthcare and Bracco
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Wolfgang A. Linke, Phd,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lilian Martinez-Carrera,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NeurOmics project has received funding from the European Union?s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 2012-305121.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Markus Storbeck, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
The NeurOmics project has received funding from the European Union?s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 2012-305121
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Brunhilde Wirth, PhD,
non profit entity; SMA Europe
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
European Community's Seventh Framework Program EFP7/2007-2013 under grant agreement no 2012-305121 (Project acronym NeurOmics)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sabine Hoffjan, MD and
NONE
NONE
NONE
Associate Editor MCP Journal (Elsevier) since 2015
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Matthias Vorgerd, MD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Cardiovascular Physiology (A.U., T.D., W.A.L.), Center for Rare Diseases Ruhr (A.U., G.D., A.G., T.D., R.K., M.T., C.H., W.A.L., S.H., M.V.), Department of Human Genetics (G.D., S.H.), Department of Neurology, Heimer Institute for Muscle Research, University Hospital Bergmannsheil (A.G., R.K., M.T., M.V.), and Institute for Pediatric Radiology, Katholisches Klinikum Bochum (C.H.), Ruhr University Bochum; Klinikum Kassel (A.F.), Kassel Medical School; Institute of Neuropathology (J.W.), RWTH University Hospital Aachen; and Institute of Human Genetics (L.M.-C., M.S., B.W.), Center for Molecular Medicine and Institute for Genetics, University of Cologne, Germany.
- Correspondence to Dr. Unger: unger.andreas{at}rub.de or Dr. Vorgerd: matthias.vorgerd{at}bergmannsheil.de
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Distinct muscle imaging patterns in myofibrillar myopathiesD. Fischer, R. A. Kley, K. Strach et al.Neurology, September 02, 2008 -
Article
Isolated inclusion body myopathy caused by a multisystem proteinopathy–linked hnRNPA1 mutationRumiko Izumi, Hitoshi Warita, Tetsuya Niihori et al.Neurology Genetics, September 24, 2015 -
Articles
Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studiesC. Paradas, J. Llauger, J. Diaz-Manera et al.Neurology, June 23, 2010 -
Research Articles
Selection Approach to Identify the Optimal Biomarker Using Quantitative Muscle MRI and Functional Assessments in Becker Muscular DystrophyNienke M. van de Velde, Melissa T. Hooijmans, Aashley S.D. Sardjoe Mishre et al.Neurology, June 23, 2021